Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia. (Q35010979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

title

Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

author name string

K M Fock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

E K Teo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

T S Chua

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

T M Ng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

Y L Tan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

3091-3098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease

12 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Reflux disease: the disorder of the third millennium.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Gastro-oesophageal reflux disease in Asia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Omeprazole 10 Milligrams Once Daily, Omeprazole 20 Milligrams Once Daily, or Ranitidine 150 Milligrams Twice Daily, Evaluated as Initial Therapy for the Relief of Symptoms of Gastro-oesophageal Reflux Disease in General Practice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305846

Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole

8 July 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal

21 January 2018

1 reference

https://api.crossref.org/works/10.3748/WJG.V11.I20.3091

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns

21 January 2018

1 reference

12 December 2020

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

1 reference

12 December 2020

Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms

1 reference

12 December 2020

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I20.3091

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json

12 January 2020

PubMed publication ID

15918196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15918196 AND SRC:MED&resulttype=core&format=json